Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid. (April 2018)
- Record Type:
- Journal Article
- Title:
- Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid. (April 2018)
- Main Title:
- Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid
- Authors:
- Rawat, A
Chaturvedi, S
Singh, AK
Guleria, A
Dubey, D
Keshari, AK
Raj, V
Rai, A
Prakash, A
Kumar, U
Kumar, D
Saha, S - Abstract:
- Pyrazinamide (PYZ)—an essential component of primary drug regimen used for the treatment and management of multidrug resistant or latent tuberculosis—is well known for its hepatoxicity. However, the mechanism of PYZ-induced hepatotoxicity is still unknown to researchers. Studies have shown that the drug is metabolized in the liver to pyrazinoic acid (PA) and 5-hydroxy pyrazinoic acid (5-OHPA) which individually may cause different degrees of hepatotoxicity. To evaluate this hypothesis, PYZ, PA, and 5-OHPA were administered to albino Wistar rats orally (respectively, at 250, 125, and 125 mg kg −1 for 28 days). Compared to normal rats, PYZ and its metabolic products decreased the weights of dosed rats and induced liver injury and a status of oxidative stress as assessed by combined histopathological and biochemical analysis. Compared to normal controls, the biochemical and morphological changes were more aberrant in PA- and 5-OHPA-dosed rats with respect to those dosed with PYZ. Finally, the serum metabolic profiles of rats dosed with PYZ, PA, and 5-OHPA were measured and compared with those of normal control rats. With respect to normal control rats, the rats dosed with PYZ and 5-OHPA showed most aberrant metabolic perturbations in their sera as compared to those dosed with PA. Altogether, the study suggests that PYZ-induced hepatotoxicity might be associated with its metabolized products, where 5-OHPA contributes to a higher degree in its overall toxicity than PA.
- Is Part Of:
- Human & experimental toxicology. Volume 37:Number 4(2018)
- Journal:
- Human & experimental toxicology
- Issue:
- Volume 37:Number 4(2018)
- Issue Display:
- Volume 37, Issue 4 (2018)
- Year:
- 2018
- Volume:
- 37
- Issue:
- 4
- Issue Sort Value:
- 2018-0037-0004-0000
- Page Start:
- 373
- Page End:
- 389
- Publication Date:
- 2018-04
- Subjects:
- Pyrazinamide -- 5-hydroxy pyrazinoic acid -- hepatotoxicity -- NMR -- metabolomics
Toxicology -- Periodicals
615.9 - Journal URLs:
- http://het.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/0960327117705426 ↗
- Languages:
- English
- ISSNs:
- 0960-3271
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8054.xml